Feasibility of Combining Family and Cognitive Therapy to Prevent Chronic Anorexia

Anorexia Nervosa Clinical Trial

Official title:

Feasibility of Combining Family and Cognitive Therapy to Prevent Chronic Anorexia

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02054364
• Other study ID #: 1R34MH101281
• Secondary ID: Grant Funding Nu
• Status: Completed
• Phase: N/A
• First received: January 31, 2014
• Last updated: April 26, 2017
• Start date: November 2013
• Est. completion date: November 2016

Study information

• Verified date: April 2017
• Source: Stanford University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study aims to investigate the feasibility of combining Cognitive Remediation Therapy (CRT) with Family Based Treatment (FBT) for future use in a randomized clinical trial to reduce the risk of adolescents developing persistent Anorexia Nervosa. Participants will be randomly assigned to one of two groups: one group will receive FBT and CRT, and the other group will receive FBT and art therapy.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 30
• Est. completion date: November 2016
• Est. primary completion date: November 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: 11 Years to 19 Years

Eligibility

Inclusion Criteria:

• Meets DSM-IV criteria for anorexia nervosa Lives with at least one English-speaking parent who is willing to participate Medically Stable Endorses obsessions/compulsions Adequate transportation to clinic Proficient at speaking, reading, and writing English

Exclusion Criteria:

• Previous FBT or CRT for AN Medical Instability Medical condition that may affect eating or weight

Related Conditions & MeSH terms

• Anorexia
• Anorexia Nervosa

Intervention

Behavioral:
• FBT and CRT

• FBT and art therapy

Locations

Country	Name	City	State
United States	Stanford University	Stanford	California

Sponsors (2)

Lead Sponsor	Collaborator
Stanford University	National Institutes of Health (NIH)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Full remission from AN (%MBW>95)	Weight restoration to at least 95% of Median body weight (calculated by height, weight, gender, and age)	End of Treatment (6 months)

External Links

•   Program information